Manor-Binyamini, Iris. “Positive Aspects of Coping among Mothers of Adolescent Children with Developmental Disability in the Druze Community in Israel.” Journal of Intellectual and Developmental Disability (early view; online first).
Background: The purpose of this study was to compare perceptions of coping as experienced by 240 mothers of adolescents with and without developmental disability in the Druze community in Israel. Method: The mothers completed the Sociodemographic Questionnaire, Grandparents Functional Support Assessment, Family Adaptability and Cohesion Evaluation Scales, and the Posttraumatic Growth Inventory. Results: Both groups were found to be similar in their perception of family cohesion and emotional support. However, mothers of adolescents with a developmental disability reported higher rates of both adaptability to change and personal growth. Moreover, associations were found between family cohesion and adaptability to change and support, and between adaptability to change and social support and personal growth. Conclusion: Druze mothers of adolescents with developmental disability reveal important information regarding positive coping strategies.
Hoshen, Moshe B., Arriel Benis, Katherine M. Keyes, and Helga Zoëga. “Stimulant Use for ADHD and Relative Age in Class among Children in Israel.” Pharmacoepidemiology and Drug Safety (early view; online first).
Diagnosis of children with attention-deficit/hyperactivity disorder (ADHD) is increasing. The present study sought to identify characteristics and medication treatment patterns of children with ADHD and compare them by relative age in class, sex, ethnicity, family size, sibling order, and other socioeconomic status, as well as find trends in disparity of pharmacotherapy. This study was based on data from 1 013 149 Clalit Health Services members aged 6–17 years during 2006–2011. The use of stimulant medication is growing among children in Israel. Although the overall use does not exceed the estimated prevalence of ADHD among children, the appropriateness of prescribing to the Israeli pediatric population, especially to the youngest children in class, may be questionable.
Mahajnah, M., R. Sharkia, N. Shorbaji, R. Terkel-Dawer, and N. Zelnik. “P173 – 2561: The Clinical Profile of ADHD in Israel – Impact of Ethnic and Social Diversities.” European Journal of Paediatric Neurology 19, sup. 1 (2015): S142 ff.
The diagnosis of ADHD relies mostly on clinical observation and employment of standard questionnaires and checklist batteries which are highly susceptible to human factors. In this study we searched for differences in the clinical profile of children with ADHD in both the Arab and Jewish sectors in Israel which might be influenced by cultural and social background.
Data of children aged 7–17 years diagnosed with ADHD between 2010 and 2013 in two ADHD clinics in northern Israel was analyzed. The diagnosis of ADHD was based on clinical evaluation and fulfillment of the DSM IV criteria and aided by both the Teacher and Parent Conners Rating Scales. Children with autism and intellectual disabilities were excluded.
Out of 823 patients – 516 (62.7%) were Jewish and 307 (37.3%) were Arabs. The distributions of the ADHD subtypes were similar in both populations. Learning disabilities (LD) and psychiatric comorbidities (behavioral difficulties and anxiety) were reported more frequently in the Jewish population (49% vs. 41% for LD, 15.7% vs. 12.8% for behavioral difficulties and 27.0% vs. 1.0% for anxiety p<0.05). Patients from the Jewish sector were primarily treated with long-acting methylphenidate formulations while patients from the Arab sector were treated primarily with short acting methylphenidate (p<0.05). The most commonly reported adverse effects were anorexia, headache, insomnia and rebound effect and were more frequently reported in the Jewish population (42.0% vs. 18.0% P<0.05).
This study demonstrates that while the biological nature of ADHD and its subtypes are similar in these two populations, learning disabilities, psychiatric co morbidities, employment of long-acting MPH formulations and complaints of side-effects were more prevalent in patients from the Jewish sectors. We presume that these differences are related to cultural and socioeconomic factors and the physician should take them into consideration when treating patients with ADHD.